Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder

NCT02662309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: MPDL3280A

Sponsor

Queen Mary University of London

Collaborators

[object Object]